article thumbnail

Understanding the Difference Between Heart Attack and Cardiac Arrest

MIBHS

When discussing heart health, heart attacks and cardiac arrest are two terms that are often mistaken for one another. Understanding the difference between heart attack and cardiac arrest can help in recognizing symptoms, seeking prompt medical care, and even saving lives. What is a Heart Attack?

article thumbnail

Chelation Therapy Does Not Improve Outcomes after Heart Attack

DAIC

The TACT2 study was designed to replicate the results of a previous trial, TACT , which reported in 2012 that chelation reduced subsequent cardiovascular events after a heart attack. and Canadian patients with diabetes and a history of heart attack,” said Gervasio A. and Canada.

article thumbnail

Cell-based therapy improves outcomes in a pig model of heart attacks

Medical Xpress - Cardiology

In a large-animal model study, researchers have found that heart attack recovery is aided by the injection of heart muscle cell spheroids derived from human-induced pluripotent stem cells (hiPSCs), that overexpress cyclin D2 and are knocked out for human leukocyte antigen classes I and II.

article thumbnail

SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. Researchers tracked outcomes for a median of just under 18 months. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries.

article thumbnail

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

DAIC

The typical survival rate of this deadly complication during a heart attack has historically hovered around 50%. Final results from the national study published in the Journal of the American Heart Association were achieved from looking at 406 patients from hospitals across 29 states. In the U.S.,

article thumbnail

No Reduction in 90-Day Deaths, Heart Attacks With Human Apo/A1, A Building Block of HDL Cholesterol

DAIC

milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.

article thumbnail

EMPACT-MI Trial Outcomes Reported at ACC24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

DAIC

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,